About Sovereign
Traditional knowledge, grounded in modern science.
Sovereign Life Sciences is a pre-seed company developing plant-based reproductive medicine — beginning with a non-hormonal, reversible contraceptive for men, and building toward a broader practice of regenerative medicine rooted in plants and the people who understand them.
Mission
Develop the world's first clinically validated plant-based male contraceptive — honouring indigenous knowledge and whole-plant integrity — while advancing sexual and relational sovereignty and a better life for all people.
Success means direct, clinically-backed contraceptive efficacy claims and mainstream adoption — bringing this to millions of men through clinical validation, sound IP, and an ethical partnership model. The longer arc builds on reproductive sovereignty as a foundation for a new paradigm of regenerative medicine: one that bridges ancient wisdom with modern science and restores humanity's relationship with the natural world as a source of wellness.
The team
The people behind the work.
Chris founded Sovereign on a belief that good medicine starts with good relationships. Through his personal and professional journey, including building Eros & Soul, an intimacy and relational development practice, he came to see the challenges many women face with modern birth control and how few choices men have. When the Indonesian research on this plant stalled, he saw an opportunity, and felt a responsibility, to carry it forward. He built Sovereign’s foundation and corporate structure with the small-town prairie tenacity he grew up with, and works alongside a small, dedicated team of advisors who each bring something crucial to the work.
Alejandro brings the business-building side to Sovereign: planning, capital discipline and the operating model that carries a funded study through to a first product. An alumnus of McKinsey & Company, Partners in Performance (part of Accenture) and KPMG, he has led strategy and performance work across mining, manufacturing, financial services, telecom and e-commerce in 15 countries, co-founded a search fund where he built investment cases for co-investors, and ran strategic planning for Argentina's 2018 G20 presidency. He holds an MBA (magna cum laude) from IAE Business School, works in English, Spanish and Portuguese, and advises Sovereign on strategy, operations and the road to investors.
Core values
What we hold to.
Ethical, regenerative product development
Developing health and wellness products through methods that respect all life, promote wellbeing, and favour natural, whole-plant approaches wherever sound.
Scientific rigour informed by traditional knowledge
Grounding our research in rigorous science with inspiration from the traditional knowledge systems — and the relationships between people, plants, and place — from which our work originates.
Equitable partnership with source communities
Partnering with knowledge-keepers and source communities through fair, transparent benefit-sharing, and supporting the cultural and linguistic vitality of the communities we work with.
Equitable global access
Making the benefits of our research accessible at scalable price points to people across all economic circumstances, including in the developing world.
Cooperative, win-win enterprise
Operating through a cooperative rather than extractive model, seeking outcomes that benefit shareholders, communities, ecosystems, and the planet.
Relational wealth
Fostering healthy, vibrant, and deeply supportive relationships of every kind — intimate, familial, communal, and professional — and advancing the education and awareness that help people build them.
Values quoted from the company's Articles of Incorporation, Part 1.1.
The company
Sovereign Life Sciences.
Sovereign Life Sciences carries the research, IP, and science — scientific validation, formulation development, and the regulatory pathway. It is a BC Benefits company, structured with formal ethical commitments to stakeholders, including indigenous partners, environmental impact, and global access, alongside investor returns.
Incorporated in British Columbia in 2025 and pre-seed, with institutional laboratory partnerships and operations anchored in Canada and Costa Rica.
Get involved
It takes a village.
Investors, advisors, and partners welcome.
Stay in the loop
Updates on the project, and first word when protocols become available.